Osaic Holdings’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
VPC
EP
VCM
YCM
IC
EAM
Osaic Holdings's PASG Position: Q1 2026 in Review
Osaic Holdings reduced its Passage Bio (PASG) stake by 25% in Q1 2026, selling an estimated $52 and leaving 15 shares worth $117. The position accounts for ﹤0.01% of the portfolio, ranked #7615.
Osaic Holdings first reported a position in PASG in Q1 2021 and has held it in 20 quarters since. The position peaked at $4K in Q1 2021. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.
- Osaic Holdings held 15 shares of Passage Bio worth $117 as of Q1 2026.
- Osaic Holdings sold 5 Passage Bio shares in Q1 2026, an estimated $52.
- Passage Bio made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7615 holding.
- Osaic Holdings first reported a position in Passage Bio in Q1 2021 and has held it in 20 quarters since.
- Osaic Holdings's Passage Bio position peaked at $4K in Q1 2021.
- 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.